Form 4 · LLY
Eli Lilly director Jon R. Moeller reports an award of about 168 shares
Part of a grouped insider digest: see all related filings with totals →
Jon R. Moeller, an Eli Lilly director, filed a Form 4 on Nov 17, 2026 at 4:19 PM ET reporting transactions on Nov 16, 2026.
The filing reports about 168 shares in a grant or award (code A).
After these transactions, the filing lists about 473 shares held directly.
Effect on holdings
Taken together, the rows reported here raised Jon R. Moeller's directly held shares by 54.9%, from about 305 to about 473.
Reporting person
- Jon R. Moeller, director (as filed: Moeller Jon R)
Transactions as reported
| Date | Code | Security | Shares | Price | Acquired or disposed | Held after | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-11-16 | A | Common Stock | 168 | $1,431.67 | Acquired | 473 | Direct |
Codes: P purchase, S sale, A grant or award, M/X/C exercise or conversion, F shares withheld for taxes or the exercise price, G gift. Prices are as reported; some are weighted averages of several trades.
Source
- Form 4 filed Nov 17, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Eli Lilly company file → · More Eli Lilly filings
Disclosures
- Editor holdings in LLY
- The editor holds no position in Eli Lilly (LLY). As of Nov 11, 2026.
- Last updated
- Nov 17, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold LLY.